The reduction in price target by Piper Sandler, despite maintaining an Overweight rating, could lead to a negative short-term sentiment among investors. This adjustment reflects a change in the expected future performance of Conmed, potentially due to revised earnings forecasts or market conditions. Such a significant decrease in the price target might cause concern among investors, leading to a short-term decrease in stock price.